Key facts
- Notable investors include Guoyao Venture Capital, Binhu State-owned Capital Operation Holding Group, Zhejiang Collaboration Investment Management.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Guoxin Diagnostics
- ·The full record, as it builds
Funding rounds
No funding rounds for Guoxin Diagnostics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Guoxin Diagnostics
Manufacturer of in vitro diagnostic products and biotechnology materials serving healthcare and laboratory sectors. The company produces diagnostic reagents, testing kits, biological raw materials, detection systems, and related medical testing products, enabling accurate disease detection, improved laboratory efficiency, and support for clinical diagnostics.
- Sector
- Healthcare
- HQ
- Hefei, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Guoxin Diagnostics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Guoxin Diagnostics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Guoxin Diagnostics in its N-PORT filings yet. We sweep new filings monthly.